๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University201 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School89 Nanjing First Hospital, Nanjing Medical University68 The Second Hospital of Nanjing Medical University32 Nanjing Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Nanjing

1193 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
NCT07355218Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Shijiazhuang, Luoyang, Nanjing, Jinan, Chengdu
2026-04-01
Recruiting
The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder
NCT07324057Autism Spectrum Disorder
Sun Fei
Not applicable
234
Nanjing
2026-04-01
Not yet open
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
NCT07481903Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not applicable
228
Beijing, Nanjing, Qingdao, Tianjin
2026-04
Not yet open
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
NCT07511309Atherosclerotic Renal Artery Stenosis, Fractional Flow Reserve, Optimal Medical Therapy, Stent Implantation
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
300
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Changchun, Jinan
2026-03-31
Active, closed
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
NCT07499050Healthy Volunteers, Overweight or Obesity
Hoffmann-La Roche
Phase 1
30
Nanjing, Shanghai
2026-03-30
Recruiting
Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?
NCT07322705Femoroacetabular Impingement Syndrome
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Taiโ€™an, Shanghai, Chengdu
2026-03-30
Recruiting
Dihydroartemisinin for MAFLD
NCT07679542MAFLD
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
30
Nanjing
2026-03-30
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb
Phase 1/2
474
Beijing, Guangzhou, Tianjin, Harbin, Changsha Shi, Nanjing, Shanghai Shi
2026-03-26
Recruiting
ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
NCT07759934Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 2
60
Nanjing
2026-03-25
Recruiting
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
NCT07353645Colorectal Cancer, Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
49
Nanjing
2026-03-23
Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
NCT07293260Cardiovascular Disease
Amgen
Phase 3
406
Beijing, Zhengzhou, Changsha, Nanjing, Yinchuan, Xi'an, Jinan
2026-03-23
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
NCT07355296Proteinuric Kidney Diseases
Boehringer Ingelheim
Phase 2
132
Beijing, Chengdu, Guangzhou, Nanchang, Nanjing, Nanning, Shanghai, Sichuan
2026-03-23
Recruiting
Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability
NCT07504731Acute Respiratory Distress Syndrome (ARDS)
Zhongda Hospital
Observational
40
Nanjing, Jinan, Chengdu
2026-03-20
Not yet open
TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease
NCT07480317PARKINSON DISEASE (Disorder)
Jiangsu Province Nanjing Brain Hospital
Not applicable
75
Nanjing
2026-03-20
Recruiting
Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension
NCT07803835Essential Hypertension, Healthy Volunteers
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
46
Nanjing
2026-03-19
Recruiting
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
NCT07446738Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca
Observational
200
Changchun, Changsha, Chengdu, Guangzhou, Haikou, Kunming, Nanchang, Nanjing
2026-03-19
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase โ…ข Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
NCT07672561Moderate to Severe Plaque Psoriasis
Zhejiang Wenda Pharma Technology LTD.
Phase 3
375
Nanjing
2026-03-18
Recruiting
Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
NCT07498478Breast Cancer
TransThera Sciences (Nanjing), Inc.
Phase 2
94
Guangzhou, Wuhan, Changsha, Nanjing, Jinan, Linyi, Hangzhou, Beijing
2026-03-17
Recruiting
Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage โ…ข Gastric Cancer: A Prospective, Multicenter, Randomized, Phase โ…ก Clinical Trial
NCT07474324GC/GEJC
The First Affiliated Hospital with Nanjing Medical University
Phase 2
124
Nanjing
2026-03-15
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Hefei, Shanghai, Guangzhou, Zhengzhou, Hangzhou, Nanjing, Xuzhou, Nanchang
2026-03-13
Recruiting
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
NCT07419828Chronic Kidney Disease
Shandong Suncadia Medicine Co., Ltd.
Phase 3
5,386
Nanjing
2026-03-13
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
NCT07421700Urothelial Cancer, Advanced/Metastatic Urothelial Cancer, Urothelial Carcinoma
Pfizer
Phase 1/2
132
Beijing, Nanjing, Tianjin, Ningbo
2026-03-11
Not yet open
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
NCT07486479Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 3
204
Hefei, Luoyang, Wuhan, Changzhou, Huai'an, Jingjiang, Lianyungang, Nanjing
2026-03-10
Recruiting
Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases
NCT07452250Venous Diseases
Min Zhou
Phase 2
50
Nanjing
2026-03-08
Recruiting
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
NCT07585370Herpes Zoster
Jiangsu Province Centers for Disease Control and Prevention
Observational
24,740
Nanjing
2026-03-06
Recruiting
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
NCT07349069Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3
5,500
Nanjing, Shanghai
2026-03-04
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-03-02
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
NCT07396480Venentoclax, Myeloid Malignancies, Conditioning, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
First Affiliated Hospital of Zhejiang University
Phase 3
186
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Hangzhou
2026-03-01
Not yet open
A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT)
NCT07471165Locally Advanced Perihilar Cholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
25
Nanjing
2026-03-01
Recruiting
Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy
NCT07452848Gallbladder Diseases, Cholelithiasis
West China Hospital
Observational
2,000
Hefei, Chongqing, Guangzhou, Harbin, Wuhan, Nanjing, Tianjin
2026-03-01
Not yet open
A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma
NCT07392866Hepatocellular Carcinoma (HCC)
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 2/3
120
Nanjing, Shanghai
2026-03-01
Recruiting
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
NCT07441174Solid Tumor Cancer, PDAC
InxMed (Shanghai) Co., Ltd.
Phase 1/2
92
Beijing, Fuzhou, Guangzhou, Zhengzhou, Luoyang, Changsha, Nanjing, Shengyang
2026-02-28
Recruiting
Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors
NCT07487597Solid Tumor
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1
24
Nanjing
2026-02-28
Recruiting
A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors
NCT07229638Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
70
Nanjing, Shanghai
2026-02-27
Active, closed
Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
NCT07308392Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
119
Nanjing
2026-02-25
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
NCT07391657Relapsed Refractory Multiple Myeloma
AstraZeneca
Phase 3
508
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hefei, Nanchang, Nanjing
2026-02-23
Not yet open
Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX
NCT07391826Stage III Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
48
Nanjing
2026-02-15
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Recruiting
Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation
NCT07397234Superior Laryngeal Nerve Block
Nanjing First Hospital, Nanjing Medical University
Not applicable
94
Nanjing
2026-02-11
Not yet open
Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD
NCT07418177AMD - Age-Related Macular Degeneration
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
9
Nanjing
2026-02-10
Not yet open
Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.
NCT07444346Coronary Artery Calcification, Coronary Artery Disease
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2026-02-10
Recruiting
Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib
NCT07396454HER2-Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
39
Nanjing
2026-02-10
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NCT07227415Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer, Renal Neoplasm
Pfizer
Phase 1/2
224
Beijing, Chongqing, Wuhan, Changsha, Nanjing, Jinan, Ningbo
2026-02-10
Recruiting
PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.
NCT07410520Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2026-02-07
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
NCT07321886Obesity, Overweight
Eli Lilly and Company
Phase 3
1,980
Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing
2026-02-06
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511Multiple Myeloma
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
Y-4 to Treat the Postherpetic Neuralgia
NCT07275762Postherpetic Neuralgia, Y-4, Pregabalin
Neurodawn Pharmaceutical Co., Ltd.
Phase 2
160
Nanjing
2026-02-02
Not yet open
Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery
NCT07348328Cardiovascular Surgical Procedures, Major Adverse Cardiovascular Events (MACE)
Nanjing Medical University
Not applicable
1,000
Shanghai, Nanjing
2026-02-01
Recruiting
Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZRยฒ) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma
NCT07418190Relapsed/Refractory Follicular Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
33
Nanjing
2026-02-01
Recruiting
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
NCT07573735Atopic Dermatitis (Eczema)
Zhongda Hospital
Observational
80
Nanjing
2026-02-01
Recruiting
Safety of Robotic Surgery for GISTs at Special Anatomic Sites
NCT07405125Gastrointenstinal Stromal Tumor (GIST)
The First Affiliated Hospital with Nanjing Medical University
Not applicable
182
Nanjing
2026-02-01
Not yet open
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
NCT07331454Gastric Cancer (GC)
The First Affiliated Hospital with Nanjing Medical University
Phase 3
335
Nanjing
2026-02-01
Not yet open
Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer
NCT07407452Ovarian Cancers
Jiangsu Cancer Institute & Hospital
Phase 2
50
Nanjing
2026-02-01
Not yet open
FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma
NCT07314372Unresectable Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma (HCC), Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
86
Nanjing
2026-02-01
Not yet open
SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma
NCT07347288PTCL
The First Affiliated Hospital with Nanjing Medical University
Phase 2
30
Nanjing
2026-02
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Beijing, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Recruiting
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
NCT07438106Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
The First Affiliated Hospital with Nanjing Medical University
Phase 2
30
Nanjing
2026-01-28
Recruiting
AI-Assisted Remote Insulin Pump Optimization in T1DM
NCT07732777Type 1 Diabetes Mellitus, Type 1 Diabetes (T1D)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
50
Nanjing
2026-01-28
Recruiting
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT07228312Intracranial Aneurysm
Johnson & Johnson Medical (Shanghai) Ltd.
Observational
200
Chenzhou, Guangzhou, Nanjing, Nanyang, Taiyuan, Wuhu, Zhengzhou
2026-01-28
Recruiting
Clinical Study for Dimethyl Fumarate in Preserving Islet ฮฒ-Cell Function in Type 1 Diabetes Mellitus
NCT07258394Type 1 Diabetes
Nanjing Medical University
Phase 3
90
Nanjing
2026-01-27
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
NCT07281976Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
220
Guangzhou, Harbin, Zhengzhou, Nanjing, Changchun, Shenyang
2026-01-27
Recruiting
Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
NCT07318259Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Nanjing
2026-01-26
Recruiting
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
NCT07351669HCC - Hepatocellular Carcinoma, TACE(Transcatheter Arterial Chemoembolization), CT
Zhongda Hospital
Observational
121
Nanjing
2026-01-20
Recruiting
Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS
NCT07362537ARDS
Southeast University, China
Not applicable
40
Nanjing
2026-01-20
Recruiting
Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.
NCT07396337Acute Ischemic Stroke
Changzhou Qianhong Bio-pharma Co., Ltd.
Phase 2
320
Nanjing
2026-01-19
Not yet open
Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study
NCT07311915Prostate Cancer
Zhongda Hospital
Not applicable
30
Nanjing
2026-01-15
Recruiting
Electro-Acupuncture in Lung cancER : EALER Study
NCT07337096Non Small Cell Lung Cancer, Accupuncture, PD-1 Inhibitors
Guangzhou University of Traditional Chinese Medicine
Not applicable
424
Guangzhou, Nanjing
2026-01-15
Recruiting
Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer
NCT07831993Biliary Tract Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
54
Nanjing
2026-01-14
Active, closed
A Study of SYH2069 Injection in Healthy Participants
NCT07736391Overweight or Obesity, Diabetes
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
104
Nanjing
2026-01-10
Recruiting
7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy
NCT07232095Helicobacter Pylori
The First Affiliated Hospital with Nanjing Medical University
Phase 4
316
Nanjing
2026-01-08
Recruiting
Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally Advanced Biliary Tract Cancer
NCT07797816Biliary Tract Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
31
Nanjing
2026-01-08
Recruiting
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
NCT07441993Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Active, closed
Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression
NCT07585877Myopia Progressing, Myopia
Zhongda Hospital
Not applicable
104
Nanjing
2026-01-05
Not yet open
A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)
NCT07365371Polypoidal Choroidal Vasculopathy (PCV), Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
174
Beijing, Foshan, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Jilin City
2026-01-01
Recruiting
Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
NCT07349875Coronary Artery Disease (CAD)
Nanjing First Hospital, Nanjing Medical University
Phase 4
3,826
Nanjing
2026-01-01
Recruiting
Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry-Based Observational Study
NCT07284888Acute Respiratory Distress Syndrome
Southeast University, China
Observational
1,000
Nanjing
2026-01-01
Recruiting
Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction
NCT07537296Acute Myocardial Infarction (AMI)
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Nanjing
2026-01-01
Not yet open
Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS
NCT07327268ARDS (Acute Respiratory Distress Syndrome), Electrical Impedance Tomography (EIT), Pulmonary Perfusion
Southeast University, China
Observational
40
Nanjing
2026-01-01
Recruiting
Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma
NCT07310173HCC - Hepatocellular Carcinoma
Zhejiang Hisun Pharmaceutical Co. Ltd.
Phase 2
75
Nanjing
2026-01-01
Recruiting
Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease
NCT07299240Parkinson Disease (PD), Insomnia
Jiangsu Province Nanjing Brain Hospital
Not applicable
48
Nanjing
2026-01-01
Not yet open
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
NCT07315035Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University
Phase 2
74
Nanjing
2026-01-01
Recruiting
Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study
NCT07311577Ovarian Cancer Metastatic, Ovarian Cancer Metastatic Recurrent
Jiangsu Cancer Institute & Hospital
Phase 2
43
Nanjing
2026-01-01
Recruiting
40 Hz Flickering for Insomnia in Parkinson's Disease
NCT07323121Parkinson Disease, Insomnia
Jiangsu Province Nanjing Brain Hospital
Not applicable
30
Nanjing
2026-01-01
Recruiting
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
NCT07297641PCI, In-stent Restenosis, Intravascular Imaging Device
Nanjing First Hospital, Nanjing Medical University
Observational
1,500
Nanjing
2026-01-01
Not yet open
Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )
NCT04104854Coronary Heart Disease
Nanjing First Hospital, Nanjing Medical University
Not applicable
220
Nanjing
2026-01-01
Not yet open
Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )
NCT04119986Coronary Heart Disease
Nanjing First Hospital, Nanjing Medical University
Not applicable
220
Nanjing
2026-01-01
Recruiting
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07331467Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Nanjing
2026-01
Not yet open
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD
Phase 1
36
Bengbu, Beijing, Luoyang, Wuhan, Nanjing, Shanghai
2026-01
Not yet open
Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
NCT07328919Intrahepatic Cholangiocarcinoma (Icc), Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.
Phase 3
138
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2026-01
Not yet open
Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
NCT06728605Coronary Heart Disease (CHD), Cardio-pulmonary Bypass, Congestive Heart Failure Chronic, Cardiogenic Shock Acute
Nanjing Medical University
Not applicable
400
Nanjing
2025-12-31
Recruiting
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
NCT07289763Primary Membranous Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
75
Nanjing
2025-12-31
Recruiting
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711Acute Respiratory Distress Syndrome
Southeast University, China
Observational
500
Nanjing
2025-12-29
Recruiting
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
NCT07298200Advanced Gastric Cancer
Jia Wei
Phase 1
18
Nanjing
2025-12-26
Recruiting
Peg IFNฮฑ-2b Therapy for Unresectable Mid to Late Stage HBV-HCC
NCT07769827HBV-HCC, Unresectable Advanced HBV-related Liver Cancer
Jinling Hospital, China
Not applicable
33
Nanjing
2025-12-26
Active, closed
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
NCT07285902Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
572
Beijing, Nanjing
2025-12-25
Not yet open
Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma
NCT05912582Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Observational
60
Nanjing
2025-12-25
Active, closed
Efficacy and Safety of a Novel ERCP Robot in the Treatment of Common Bile Duct Stone
NCT07368335ERCP, Robot Surgery, Common Bile Duct Stone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
200
Nanjing
2025-12-24
Recruiting
ฮฒ-alanine in the Treatment of Advanced Hepatocellular Carcinoma
NCT07317414Hepatocellular Carcinoma
Peking Union Medical College Hospital
Phase 2
158
Beijing, Nanjing, Xuzhou
2025-12-24
Recruiting
Food Intake-Related Brain and Metabolic Responses in Obesity
NCT07392905Obesity, Brain Function, Metabolomics, Feeding Behavior
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
60
Nanjing
2025-12-21
Rows per page Showing 201–300 of 1193
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,193 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

713 of the 1,193 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 232 have not yet opened recruitment, 216 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.